IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and Obesity

IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and Obesity

Obesity is a significant factor for increased morbidity and mortality upon infection with SARS-CoV-2. Because of the higher potential for negative outcomes following infection of individuals with obesity, the impact of body mass index (BMI) on vaccine immunogenicity and efficacy is an important publ...

Full description

Bibliographic Details
Main Authors: John T. Bates, Andrew P. Farmer, Michael A. Bierdeman, Dallas R. Ederer, Lauren S. Carney, Denise D. Montgomery, Seth T. Lirette, Gailen D. Marshall
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccination
obesity
body mass index
IgG
mRNA vaccine
Online Access:https://www.mdpi.com/2076-393X/10/4/512

Internet

https://www.mdpi.com/2076-393X/10/4/512

Similar Items